Matthew Freeby

Endocrinology in New York, New York

Practice Details

Address
1150 Saint Nicholas Ave
New York, NY 10032
Geocoded location: 40.8404, -73.9396
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2008
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
December 2024

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 343 Endocrinology, Diabetes & Metabolism practices in New York carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • •A review of diabetes, thyroid, or metabolic history and current medications.
  • •Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • •A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • •Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Matthew Freeby's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 212-851-5494.

GLP-1 access in New York, New York

Adult obesity rate
28.9%
#41 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$229/mo
Typical New York telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New York Medicaid, obesity indication

About 28.9% of New York adults have obesity (BMI 30+), ranking the state #41 of 50 (CDC BRFSS). Our directory currently lists 540 GLP-1-relevant clinics in New York. If a cash-pay route makes more sense, compounded semaglutide through New York telehealth averages about $229/mo — well below brand-name Wegovy or Zepbound.

Explore more New York options on the best New York GLP-1 providers page, browse every New York listing in the New York clinic directory.

Related Practices in New York

Other New York listings in the same directory tier:

Martin Rothschild
Endocrinology
Melina Manolas
Endocrinology
Martin Nydick, P.C.
Endocrinology

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New York addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New York telehealth partners:

Featured Partners · New York

Featured GLP-1 providers serving New York

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 182 GLP-1 providers serving New York ↓

See more New York options on the New York clinic directory, our New York GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by New York obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Matthew Freeby's specialty taxonomy but not the specific medications it prescribes or its current service menu. Matthew Freeby is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 212-851-5494 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Matthew Freeby's primary specialty on file is Endocrinology.
Matthew Freeby is located at 1150 Saint Nicholas Ave, New York, NY 10032. The phone number listed in the registry is 212-851-5494. Its full record is public in the CMS National Provider registry under NPI 1013189646.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Matthew Freeby is currently accepting new patients. Call the practice at 212-851-5494 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.